Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of Th17 immunity.
Chia-Hao LinCheng-Jang WuSunglim ChoRasika PatkarLing-Li LinMei-Chi ChenElisabeth IsraelssonJoanne BettsMagdalena NiedzielskaShefali A PatelHan G DuongRomana R GernerChia-Yun HsuMatthew CatleyRose A MaciewiczHiutung ChuManuela RaffatelluJohn T ChangLi-Fan LuPublished in: bioRxiv : the preprint server for biology (2023)
Regulatory T (Treg) cells are instrumental in establishing immunological tolerance. However, the precise effector mechanisms by which Treg cells control a specific type of immune response in a given tissue remains unresolved. By simultaneously studying Treg cells from different tissue origins under systemic autoimmunity, here we show that IL-27 is specifically produced by intestinal Treg cells to regulate Th17 immunity. Selectively increased intestinal Th17 responses in mice with Treg cell-specific IL-27 ablation led to exacerbated intestinal inflammation and colitis-associated cancer, but also helped protect against enteric bacterial infection. Furthermore, single-cell transcriptomic analysis has identified a CD83 + TCF1 + Treg cell subset that is distinct from previously characterized intestinal Treg cell populations as the main IL-27 producers. Collectively, our study uncovers a novel Treg cell suppression mechanism crucial for controlling a specific type of immune response in a particular tissue, and provides further mechanistic insights into tissue-specific Treg cell-mediated immune regulation.
Keyphrases
- single cell
- induced apoptosis
- immune response
- regulatory t cells
- cell cycle arrest
- cell therapy
- rna seq
- dendritic cells
- oxidative stress
- high throughput
- cell death
- endoplasmic reticulum stress
- transcription factor
- cell proliferation
- type diabetes
- inflammatory response
- skeletal muscle
- insulin resistance
- pi k akt
- young adults
- papillary thyroid